Senti Biosciences
Focus: Senti Biosciences is a South San Francisco-based biotech focused on gene circuits and cell & gene therapies across respiratory, infectious disease, and oncology indications. The company operates at early clinical stage with multiple Phase 1 programs and investigational device platforms.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Open Jobs
0
About Senti Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Senti Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Senti Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Senti V1.0 Device
Respiratory DiseaseClinical Trials (1)
NCT04693091Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology
N/AHelp build intelligence for Senti Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.